14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model

被引:20
|
作者
Underwood, Rachel [1 ,3 ]
Gannon, Mary [1 ]
Pathak, Aneesh [1 ]
Kapa, Navya [1 ]
Chandra, Sidhanth [1 ,4 ]
Klop, Alyssa [1 ]
Yacoubian, Talene A. [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA
[2] Civitan Int Res Ctr, Room 510A,1719 Sixth Ave South, Birmingham, AL 35294 USA
[3] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Maloney Bldg,3rd Floor,3600 Spruce St, Philadelphia, PA 19104 USA
[4] Northwestern Univ, Med Scientist Training Program, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
14-3-3s; Alpha-synuclein; Parkinson's disease; Dementia with Lewy Bodies; Substantia nigra; Amygdala; Cortex; Mouse;
D O I
10.1186/s40478-020-01110-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alpha-synuclein (alpha syn) is the key component of proteinaceous aggregates termed Lewy Bodies that pathologically define a group of disorders known as synucleinopathies, including Parkinson's Disease (PD) and Dementia with Lewy Bodies. alpha Syn is hypothesized to misfold and spread throughout the brain in a prion-like fashion. Transmission of alpha syn necessitates the release of misfolded alpha syn from one cell and the uptake of that alpha syn by another, in which it can template the misfolding of endogenous alpha syn upon cell internalization. 14-3-3 proteins are a family of highly expressed brain proteins that are neuroprotective in multiple PD models. We have previously shown that 14-3-3 theta acts as a chaperone to reduce alpha syn aggregation, cell-to-cell transmission, and neurotoxicity in the in vitro pre-formed fibril (PFF) model. In this study, we expanded our studies to test the impact of 14-3-3s on alpha syn toxicity in the in vivo alpha syn PFF model. We used both transgenic expression models and adenovirus associated virus (AAV)-mediated expression to examine whether 14-3-3 manipulation impacts behavioral deficits, alpha syn aggregation, and neuronal counts in the PFF model. 14-3-3 theta transgene overexpression in cortical and amygdala regions rescued social dominance deficits induced by PFFs at 6 months post injection, whereas 14-3-3 inhibition by transgene expression of the competitive 14-3-3 peptide inhibitor difopein in the cortex and amygdala accelerated social dominance deficits. The behavioral rescue by 14-3-3 theta overexpression was associated with delayed alpha syn aggregation induced by PFFs in these brain regions. Conversely, 14-3-3 inhibition by difopein in the cortex and amygdala accelerated alpha syn aggregation and reduction in NECAB1-positive neuron counts induced by PFFs. 14-3-3 theta overexpression by AAV in the substantia nigra (SN) also delayed alpha syn aggregation in the SN and partially rescued PFF-induced reduction in tyrosine hydroxylase (TH)-positive dopaminergic cells in the SN. 14-3-3 inhibition in the SN accelerated nigral alpha syn aggregation and enhanced PFF-induced reduction in TH-positive dopaminergic cells. These data indicate a neuroprotective role for 14-3-3 theta against alpha syn toxicity in vivo.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
    Rachel Underwood
    Mary Gannon
    Aneesh Pathak
    Navya Kapa
    Sidhanth Chandra
    Alyssa Klop
    Talene A. Yacoubian
    Acta Neuropathologica Communications, 9
  • [2] Effect of 14-3-3(eta) on alpha-synuclein aggregation intermediates
    Kumar, Dhruv
    Plotegher, Nicoletta
    Tessari, Isabella
    Samori, Bruno
    Brucale, Marco
    Bubacco, Luigi
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2011, 40 : 90 - 90
  • [3] A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model
    Polinski, Nicole K.
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 (04) : 1555 - 1567
  • [4] 14-3-3(eta) acts as a molecular chaperon on alpha-synuclein aggregation intermediates
    Kumar, D.
    Plotegher, N.
    Tessari, I.
    Samori, B.
    Brucale, M.
    Bubacco, L.
    FEBS JOURNAL, 2011, 278 : 266 - 266
  • [5] 14-3-30 phosphorylation exacerbates alpha-synuclein aggregation and toxicity
    Wang, Bing
    Gannon, Mary
    Pattanayak, Rudradip
    Scholz, Kasandra
    Pair, Frank Sanders
    Stone, William J.
    Ekkatine, Roschongporn
    Liu, Zhongyu
    Yacoubian, Talene A.
    NEUROBIOLOGY OF DISEASE, 2025, 206
  • [6] Analysis of alpha-synuclein aggregation and toxicity in a fission yeast model
    Brandis, K
    Holmes, I
    England, S
    DebBurman, S
    FASEB JOURNAL, 2005, 19 (04): : A317 - A318
  • [7] Cellular models of alpha-synuclein toxicity and aggregation
    Delenclos, Marion
    Burgess, Jeremy D.
    Lamprokostopoulou, Agaristi
    Outeiro, Tiago F.
    Vekrellis, Kostas
    McLean, Pamela J.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 (05) : 566 - 576
  • [8] Alpha-Synuclein Oxidative Modifications And Their Role On Fibril And Oligomer Aggregation
    Ivagnes, Rodrigo
    Chavarria, Cecilia
    Zeida, Ari
    Dolores Pineyro, Maria
    Rios, Natalia
    Maria Souza, Jose
    FREE RADICAL BIOLOGY AND MEDICINE, 2023, 208 : S160 - S160
  • [9] Alpha-synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice
    Shirakashi, Yoshitomo
    Kawamoto, Yasuhiro
    Tomimoto, Hidekazu
    Takahashi, Ryosuke
    Ihara, Masahumi
    BRAIN PATHOLOGY, 2006, 16 : S57 - S57
  • [10] Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo
    Valerie Cullen
    Maria Lindfors
    Juliana Ng
    Anders Paetau
    Erika Swinton
    Piotr Kolodziej
    Heather Boston
    Paul Saftig
    John Woulfe
    Mel B Feany
    Liisa Myllykangas
    Michael G Schlossmacher
    Jaana Tyynelä
    Molecular Brain, 2